Circulating Extracellular Vesicles as Promising Biomarkers for Precession Diagnostics: A Perspective on Lung Cancer

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Extracellular vesicles (EVs) are crucial in intercellular communication and disease progression, particularly in lung cancer.
• Their presence in bodily fluids makes them valuable biomarkers for non-invasive disease detection.
• Lung cancer diagnosis and treatment can be significantly advanced by analyzing EV cargo.

Purpose of the Study:

• To review advanced nanotechnology-based methods for detecting lung cancer using EVs.
• To explore the role of exosomes in lung cancer progression and EV analysis.
• To highlight innovations in EV isolation, detection, and cargo analysis for improved lung cancer diagnostics.

Main Methods:

• Review of nanotechnology-based techniques for EV isolation and detection.
• Analysis of microfluidic platforms and multiplexed biosensing for EV characterization.
• Examination of biomolecular signatures within EVs for diagnostic accuracy.

Main Results:

• Nanotechnology offers innovative strategies to enhance EV isolation and detection sensitivity and specificity.
• Characterizing specific EV biomolecular signatures improves diagnostic accuracy in lung cancer.
• Advanced techniques like microfluidics and multiplexed biosensing are crucial for EV analysis.

Conclusions:

• EV-based liquid biopsy, powered by nanotechnology, shows transformative potential in lung cancer diagnosis.
• Standardization of protocols and robust analytical platforms are essential for clinical translation.
• This approach heralds a new era of personalized medicine for lung cancer patients.